A new pod-based comms system for the KC-46, enabling it to serve as a 'translator' for the incompatible radio systems of the F-22 and F-35, will be fielded in the last quarter of fiscal 2022.
Sapience Therapeutics Awarded SBIR Phase I Grant from National Institute of Allergy and Infectious Diseases
News provided by
Share this article
Share this article
HARRISON, N.Y., May 18, 2021 /PRNewswire/ Sapience Therapeutics, Inc., a biotechnology company focused on the discovery and development of peptide therapeutics to address difficult to treat oncology indications, announced today that it was awarded a Small Business Innovative Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to investigate the inhibition of SARS-CoV-2 infection with a pan-coronavirus anti-viral peptide. The grant will provide funds over two years to support the discovery and development of peptide therapeutics against coronaviruses, including SARS-CoV-2 (COVID-19).
Sapience Therapeutics Awarded SBIR Phase I Grant from National Institute of Allergy and Infectious Diseases prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global scintillator market reached a value of US$ 476.5 Million in 2020. Scintillators refer to materials which can absorb high-energy photons and incident particles such as protons, electrons and neutrons. The common scintillator materials include inorganic and organic crystals, organic liquids, and noble and scintillating gases. They assist in converting the gathered energy into visible or ultraviolet range of photons which ensures detection by photomultipliers and photodiodes. Besides this, scintillators help in efficiently determining the energy and time of incident radiation. When compared to other types of radiation detectors, these materials are more sensitive to deposited energy and have a faster response time with simpler, reliable and cost-efficient construction and operation. As a result, they find vast applications in nuclear plants, medical imaging, manufacturing industries, high-energy part
Alabama company CFD Research wins contract to develop COVID-19 drugs using natural products from hot springs
Permalink
By Margetta Thomas May 14, 2021
CFD Research has been awarded a $1.5M contract to develop extremophile-derived antivirals to protect soldiers and civilians from COVID-19. Selection was based on achievements during previous drug discovery projects and a novel strategy for targeting the SARS-CoV-2 virus. (Abigail Edwards / CFD Research)
CFD Research, based in Huntsville, has been awarded a $1.5M Phase II Defense Health Agency (DHA) Small Business Innovative Research (SBIR) contract to develop extremophile-derived antivirals to protect soldiers and civilians from COVID-19.
Selection was based on achievements during previous drug discovery projects and a novel strategy for targeting the SARS-CoV-2 virus, which causes COVID-19.